Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
03/2010
03/10/2010EP2160396A2 Thiocarbon-protecting groups for rna synthesis
03/10/2010CN101668768A Process for preparing an a2a-adenosine receptor agonist and its polymorphs
03/10/2010CN101665525A Synthetic method of nucleotide
03/09/2010US7674585 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
03/04/2010WO2010023457A1 Nucleoside analogues useful as positron emission tomography (pet) imaging agents
03/04/2010US20100056771 Process of Making 2-Deoxy-2,2-Difluoro-D-Ribofuranosyl Nucleosides and Intermediates Therefor
03/04/2010US20100056770 Preparation of nucleosides ribofuranosyl pyrimidines
03/04/2010US20100056468 Pyrimidine Derivatives As Anticancer Agents
03/04/2010US20100056466 2'-Cyanopyrimidine Nucleoside Compound
03/04/2010US20100056465 Compounds, compositions and methods of using same for modulating uric acid levels
03/04/2010US20100056464 Compounds, compositions and methods of using same for modulating uric acid levels
03/03/2010EP2158208A1 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
03/03/2010EP1863827B1 Hydrogels for the controlled release of bioactive materials
03/03/2010EP1664056B1 Fused pentacyclic polyethers
03/03/2010EP0852499B1 Therapeutic azide compounds
03/03/2010CN101663313A nucleotide with an alpha-phosphate mimetic
03/02/2010US7671192 (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide; stable under relative humidity stress
03/02/2010US7671191 By reacting 2-iodoadenosine-5'-N-ethyluronamide with an propynylcyclohexyl ester of given formula; making adenosine receptor agonists; higher yields and less chromatographic purification required
02/2010
02/25/2010WO2010021897A1 Nucleosidic phosphoramidite crystalline material and a process for purifying the same
02/25/2010WO2010021344A1 Novel nucleic acid derivative, and method for preparing nuclease-resistant nucleic acid by using same
02/25/2010US20100048890 Conjugated small molecules
02/25/2010US20100048504 Crystalline and amorphous forms of beta-l-deoxythymidine
02/25/2010US20100048502 Bhq-caged nucleotide probes photolysable by two-photon excitation
02/25/2010US20100048501 Phosphorylated A2A Receptor Agonists
02/25/2010US20100048500 Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections
02/25/2010US20100047391 Reduced-salt dairy product with improved taste
02/25/2010US20100047222 Nucleic acids and polypeptides of C1 bacteriophage and uses thereof
02/24/2010EP2157182A2 Modified short interfering RNA
02/24/2010EP2157095A2 Synthesis of beta-L-2-Deoxy nucleosides
02/24/2010EP2155771A1 Azido purine nucleosides for treatment of viral infections
02/24/2010CN101654469A 5'-guanosine-disodium phosphate crystallizing method
02/24/2010CN100591685C Crystalline forms of a pharmaceutical compound
02/23/2010US7667034 Chemical synthesis of S-adenosyl-L-methionine with enrichment of (S,S)-isomer
02/23/2010US7667031 Codons
02/23/2010US7666856 Antiviral nucleosides
02/23/2010US7666855 Hepatitis C viral infection; 4-amino-7-(2', 3'-carbonyl-cis-5'-O-[4-(S)-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphorinan-2-yl]-2'-C-methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine
02/23/2010US7666851 Three ring fused analogs of isoguanosine
02/23/2010CA2502109C 4'-c-substituted-2-haloadenosine derivative
02/18/2010US20100041041 Nucleotides and nucleosides and methods for their use in dna sequencing
02/17/2010EP1427852B1 Single nucleotide amplification and detection by polymerase
02/17/2010EP1421213B1 Labeled nucleoside polyphosphates
02/17/2010CN101648984A Method for separating and purifying 5'-cytidylic acid and derivatives thereof
02/16/2010US7662938 2′-fluoronucleosides
02/16/2010US7662798 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
02/16/2010CA2442979C Process for the preparation of 2'-halo-.beta.-l-arabinofuranosyl nucleosides
02/11/2010WO2010017547A1 Process for making 5-azacytosine nucleosides and their derivatives
02/11/2010WO2010017374A1 Process for preparing azacytidine intermediate
02/11/2010WO2010015643A1 New antiviral modified nucleosides
02/11/2010WO2010015637A1 New antiviral modified nucleosides
02/11/2010WO2010015245A1 Method for producing phosphate-bridged nucleoside conjugates
02/11/2010US20100036411 Anti-no-reflow guide wire for vascular interventional procedures
02/11/2010US20100036115 Novel Compositions for the Delivery of Negatively Charged Molecules
02/11/2010US20100036112 Process for Making 5-Azacytosine Nucleosides and Their Derivatives
02/11/2010US20100036111 Method for replicating nucleic acids and novel unnatural base pairs
02/11/2010US20100036110 Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides
02/11/2010US20100035836 Bicyclic nucleosides and nucleotides as therapeutic agents
02/11/2010US20100035835 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
02/11/2010DE102008044914A1 Verfahren zur Herstellung phosphatverbrückter Nucleosid-Konjugate A process for preparing nucleoside conjugates phosphatverbrückter
02/11/2010CA2733591A1 Process for making 5-azacytosine nucleosides and their derivatives
02/10/2010EP2150572A1 Continuous counter-current organosolv processing of lignocellulosic feedstocks
02/10/2010CN101646685A Process for the synthesis of IB-MECA
02/10/2010CN101643491A Method for extracting cyclic adenosine monophosphate from dates
02/09/2010US7659070 Charge switch nucleotides
02/09/2010CA2387503C Fluorescent cobalamins and uses thereof
02/09/2010CA2350417C Dna-protein fusions and uses thereof
02/04/2010WO2010014134A1 Compounds and pharmaceutical compositions for the treatment of viral infections
02/04/2010WO2010013442A1 Light-responsive nucleotide molecule, and method for production of light-responsive modified nucleic acid by using the light-responsive nucleotide molecule
02/04/2010US20100029579 Antiviral compounds
02/04/2010US20100029494 Macromolecular Nucleotide Compounds And Methods For Using The Same
02/04/2010US20100029008 Polymerase-independent analysis of the sequence of polynucleotides
02/04/2010US20100028885 labelling nucleotides using terminal transferases, polymerases or a reverse transcriptase; sequence determination
02/04/2010US20100028319 Composition for prevention or treatment of diabetes
02/04/2010DE19854973B4 Verfahren zur Reinigung von Nukleinsäuren A method for purifying nucleic acids
02/04/2010DE102008035299A1 Conjugate, particularly bromovinyl-deoxyuridine for manufacture medicament for inhibiting or suppressing metastasis including distant metastases in cytostatic treatment, includes heat shock protein and nucleoside
02/03/2010EP2149574A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
02/02/2010US7655795 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases
02/02/2010US7655791 DNA amplification and sequencing using DNA molecules generated by random fragmentation
02/02/2010US7655638 Partial and full agonists of A1 adenosine receptors
02/02/2010US7655637 N-pyrazole A2A receptor agonists
02/02/2010US7655409 Have negatively charged substituent for fluorescent staining of DNA; used to distinguish DNA present in a sample from RNA
02/02/2010CA2196286C Parallel selex
01/2010
01/28/2010WO2010011312A1 Universal methylation profiling methods
01/28/2010WO2010010966A1 Nucleoside triphosphate derivative, nucleic acid probe, multilabeled nucleic acid probe, method for production of multilabeled nucleic acid probe, and method for detection of target nucleic acid
01/28/2010US20100022468 Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection
01/28/2010US20100022467 Anti-cancer phosphonate analogs
01/28/2010CA2730938A1 Nucleoside triphosphate derivative, nucleic acid probe, multilabeled nucleic acid probe, method for production of multilabeled nucleic acid probe, and method for detection of target nucleic acid
01/27/2010EP2147010A1 Nucleotide with an alpha-phosphate mimetic
01/27/2010EP2147009A1 Novel chromophoric silyl protecting groups and their use in the chemical synthesis of oligonucleotides
01/27/2010EP2146701A1 Biodegradable polyanhydrides with natural bioactive molecules
01/27/2010CN101633681A Method for separating and purifying deoxynucleoside triphosphate
01/26/2010US7652001 Lipophilic, potentiated ester derivatives of nucleoside/viricide derivatives; side effect reduction; viricides; antiproliferative agents; bone metabolism disorders; antimetobolic, -tumor agents and -carcinogenic agents; poxviruses; herpes viruses; influenza and hepatitis viruses
01/26/2010CA2465206C Polymeric thiol-linked prodrugs
01/26/2010CA2378370C 5-(e)-bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
01/21/2010WO2009115927A3 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
01/21/2010US20100016574 2'-Hydroxyl Group-Modified Ribonucleoside Derivatives
01/21/2010US20100016254 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
01/21/2010US20100016252 Mannich Base N-Oxide Drugs
01/21/2010US20100016251 Nucleoside phosphoramidate prodrugs
01/21/2010US20100016250 Toll-like receptor 9 agonists
01/21/2010US20100016177 Templated molecules and methods for using such molecules
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 201